BLOSSOM ANDREA DAMANIA, Ph.D.
Mount Holyoke College, Massachusetts (Bachelor of Arts) 1992.
University of Pennsylvania, Pennsylvania (Ph.D.) 1998.
Harvard Medical School, Massachusetts (Postdoctoral Fellow) 1998-2000.
Assistant Dean of Research, School of Medicine, UNC-Chapel Hill 2014-present
Director of Translational Advancements and Basic Science, 2014-present
Translational and Clinical Sciences (NC TraCS) Institute, UNC-Chapel Hill
Co-Leader, Virology Program, Lineberger Cancer Center, UNC-Chapel Hill 2014-present
Co-Director, Program in Global Oncology, Lineberger Cancer Center, UNC-Chapel Hill 2011-present
Professor, Department of Microbiology & Immunology, UNC-Chapel Hill 2011-present
Associate Professor, Department of Microbiology & Immunology, UNC-Chapel Hill 2006-2011
Assistant Professor, Department of Microbiology & Immunology, UNC-Chapel Hill 2000-2006
Fellow of the American Academy of Microbiology, 2013.
Kavli Fellow, National Academy of Sciences, USA. 2011.
Dolph O. Adams Award, Society for Leukocyte Biology, 2011.
UNC Ruth and Phillip Hettleman Prize for Artistic and Scholarly Achievement, 2008.
Burroughs Wellcome Investigator in Infectious Disease, 2006-2011.
American Heart Association Established Investigator Award, 2006-2011.
UNC Jefferson-Pilot Award in Faculty Medicine, 2005
Leukemia & Lymphoma Society Scholar, 2005-2010.
Mount Holyoke College Mary Lyon Alumnae Award, 2005.
American Association for Cancer Research (AACR) Gertrude B. Elion Research Scholar, 2004.
American Herpes Foundation Research Scholar Award. 2003.
V Foundation for Cancer Research Scholar Award. 2001-2003.
2009-present Associate Editor, PLoS Pathogens
2010-present Associate Editor, Frontiers in Microbial Immunity
2008-present Contributing Faculty Member of Faculty of 1000, Biology. Virology Section of the Microbiology Faculty.
2005-2014 Editorial Board Member for Journal of Virology
2009-2012 Editorial Board Member for Virology
2007-present Editorial Board member for The Open Virology Journal
2008-present Editorial Board member for Infection and Drug Resistance
Permanent member of VIR-A study section (2009-2013)
In summary, our lab
is interested in the study of viral oncogenes and viral
transcription factors of KSHV, host-pathogen
interactions, innate immunity, and using RRV as an
animal model system to study KSHV pathogenesis. The
projects in our laboratory encompass the areas of signal
transduction, apoptosis, angiogenesis, innate immunity,
transcription and recombinant herpesvirus production. We
employ the latest techniques in molecular biology, cell
biology, immunology and biochemistry to investigate key
issues in viral oncogenesis.
Please contact us if
you are interested in our research